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Abstract 
Objectives  Using data from a prospective birth cohort, we aimed to test for an association between 
exposure to tobacco smoke in utero or during early development and the experience of hypomania 
assessed in young adulthood. 
Methods  We used data on 2,957 participants from a large birth cohort (Avon Longitudinal Study of 
Parents and Children, ALSPAC).  The primary outcome of interest was hypomania, and the secondary 
outcome was ͚hǇpoŵaŶia plus pƌeǀious psǇĐhotiĐ eǆpeƌieŶĐes ;PEͿ͛.  MateƌŶallǇ-reported smoking 
during pregnancy, paternal smoking and exposure to environmental tobacco smoke (ETS) in 
childhood were the exposures of interest.  Multivariable logistic regression was used and estimates 
of association were adjusted for socio-economic, lifestyle and obstetric factors.  
Results  There was weak evidence of an association between exposure to maternal smoking in utero 
and lifetime hypomania.  However, there was a strong  association of maternal smoking during 
pregnancy within the sub-group of individuals with hypomania who had also experienced psychotic 
symptoms (OR = 3·45, 95%CI 1·49=7·98, P = 0·004).  There was no association between paternal 
smoking, or exposure to ETS during childhood, and hypomania outcomes. 
Conclusions  Exposure to smoking in utero may  be a risk factor for more severe forms of 
psychopathology on the mood-psychosis spectrum, rather than DSM-defined bipolar disorder. 
Key words: Tobacco, Psychoses, Post partum, Nicotine,  Bipolar Disorder 
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1. Introduction 
The adverse effects of smoking and exposure to environmental tobacco smoke (ETS) on a range of 
physical health outcomes are well documented [1 2].  Recent research suggests that exposure to ETS 
in utero can result in preterm birth, low birth weight and small gestational age [3,4,5]  and exposure 
to smoking in utero has been linked to a range of adverse neuropsychiatric outcomes in offspring [6], 
including delayed intellectual development [7], neurodevelopmental impairment [8],  attention 
deficit hyperactivity disorder (ADHD) [9], psychotic symptoms [10], schizophrenia [11,12 ], 
psychoactive substance use [13], and behavioural and emotional disorders [13]. 
It is established that nicotine, which easily crosses the placental membrane, can reach high 
concentrations in the fetal bloodstream, with deleterious effects on brain development [14], 
neurotransmitter function [15] and cognition [16].  One of the mechanisms of this may be via an 
action on nicotinic acetylcholine receptors, which influence the development of neural circuits, 
including those responsible for regulating mood [17].  Nicotine exposure in utero may also increase 
oxidative stress [18] and can cause epigenetic modifications [19]. 
To date, only two studies have assessed whether maternal smoking during pregnancy is a risk factor 
for the development of bipolar disorder (BD) in adulthood, with inconsistent results.  In a nested 
case-control analysis of data from the Child Health and Development Study (CHDS) in the United 
States, Talati and colleagues compared 79 individuals with bipolar disorder to 632 matched controls 
[17].  They identified a two-fold increase in risk for BD among offspring who had been exposed to 
maternal smoking during pregnancy, after adjusting for birth weight, maternal race, maternal 
alcohol use during pregnancy and maternal psychopathology.  More recently, Chudal and colleagues 
used data from four Finnish population and health registers to compare rates of maternal smoking 
during pregnancy between 724 individuals with BD and 1419 matched controls [20].  After adjusting 
for parental psychiatric history, maternal age and maternal educational level, there was no 
association between maternal smoking during pregnancy and risk of BD. 
In the current study, our primary aim was to assess the relationship between exposure to tobacco 
smoke in utero or during early childhood and risk of hypomania assessed in young adulthood, using 
prospective data from a large birth cohort.  We aimed to extend previous work by adjusting for a 
range of potential confounders, including ŵotheƌ͛s age at deliǀeƌǇ, ŵateƌŶal eduĐatioŶ leǀel, 
maternal social class, marital status, low income, maternal history of depression, exposure to 
influenza in utero, use of cannabis, alcohol and illicit drugs during pregnancy, offspring sex, birth 
weight and gestation at delivery.  Additionally, we take a broader view of the mood-psychosis 
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spectrum by assessing the extent to which exposure to tobacco smoke in utero impacts on risk of 
psychotic experiences in the context of a concurrent history of hypomania. 
 
2. Methods 
2.1 Description of cohort and study sample 
The ALSPAC birth cohort is comprised of all live births in the County of Avon, UK, with expected due 
dates between April 1991 and December 1992.  The initial cohort comprised 14,062 live births, with 
13,998 alive at one year (http://www.bristol.ac.uk/alspac/, accessed 19th March 2016). The ALSPAC 
website contains details of all data available in the data dictionary 
(http://www.bris.ac.uk/alspac/researchers/data-access/data-dictionary/, accessed March 19th 
2016).  Ethical approval for this study was obtained from the ALSPAC Ethics and Law Committee and 
Local Research Ethics Committees. 
Fƌoŵ ďiƌth, paƌeŶts Đoŵpleted ƌegulaƌ ƋuestioŶŶaiƌes aďout all aspeĐts of theiƌ Đhild͛s health aŶd 
development. From age 7, children attended assessment centres for tests and interviews annually.  
To date, ALSPAC data have been used in a wide range of studies in mental health [21 22]. In this 
study, we assess data on the 2,957 ALSPAC participants who completed an assessment of the 
primary outcome of interest, namely lifetime experience of hypomania, at age 22-23. 
 
2.1.1 Sample selection 
From the original ALSPAC cohort,  9,359 young adults were invited to complete the "Your Life Now 
(at age 21+)" assessments, which included the Hypomania Checklist (HCL-32) questionnaire.  
Participants could choose from paper or online versions.  A total of 3,447 participants returned the 
questionnaire (36.8% response rate), including 2,957 with complete answers (representing our study 
sample). 
 
2.2 Outcome measures 
2.2.1 Primary outcome: lifetime hypomania assessed in young adulthood 
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Hypomania was defined using the  HCL-32, assessed when participants were aged 22-23 years.  The 
HCL-32 is a self-completed questionnaire for lifetime experience of manic features  [23].  It asks 
individuals to ĐoŶsideƌ a tiŵe ǁheŶ theǇ ǁeƌe iŶ a ͞high oƌ hǇpeƌ͟ state aŶd respond to a number of 
statements about their emotions, thoughts and behaviours at this time.  Examples of the 32 
sǇŵptoŵ stateŵeŶts aƌe: ͞I think faster͟; ͞I make more jokes or puns when I am talking͟; aŶd ͞I take 
more risks in my daily life͟.  The HCL-32 also asks about the duration of episodes and any impact on 
family, social and work life [24 25]. Although initially developed as a screening instrument for use in 
people diagnosed with depressive disorders, it is also a sensitive screening tool for bipolar disorder 
type II within non-clinical settings, including samples of young adults [26 27]. 
We defined lifetime history of hypomania in line with previous approaches for studies of this nature, 
namely: a score of 14 or more out of 32 hypomanic features; plus at least one response of either 
͞Ŷegatiǀe ĐoŶseƋueŶĐes͟ oƌ ͞Ŷegatiǀe plus positiǀe ĐoŶseƋueŶĐes͟; plus a report that these mood 
changes caused a reaction in others; plus a duƌatioŶ of ͞Ϯ-ϯ daǇs͟ oƌ ŵoƌe.  Oǀeƌall, this defiŶitioŶ of 
hypomania, which includes severity, impairment and duration criteria, is much more conservative 
than other studies using the HCL-32, which have tended to use only the threshold score of 14 for 
caseness [27 28].  We chose a duration criterion of 2-3 days or more because the 4 day threshold 
within DSM excludes many individuals with bipolar disorder type II [29 30] and because two days is 
the modal duration of hypomania for individuals with bipolar II disorder [31 32]  Based on previous 
work in non-clinical samples, we expected that between 5-10% of respondents might satisfy our 
criteria for hypomania [26 33] 
 
2.2.2 Secondary outcome: hypomania with previous psychotic experiences (PE) 
͚Hypomania plus previous PE͛ was also studied as an outcome.  PE were assessed using the semi-
structured Psychosis-Like Symptoms interview (PLIKSi) administered at ages 12 and 18 [34]. The 
PLIKSi consists of 12 core questions covering hallucinations (visual and auditory); delusions 
(delusions of being spied on, persecution, thoughts being read, reference, control, grandiose ability 
and other unspecified delusions); and experiences of thought interference (thought broadcasting, 
insertion and withdrawal) over the past 6 months.  Clinical cross-questioning and probing was used 
to establish the presence of symptoms, and coding of all items followed the glossary definitions and 
rating rules for SCAN (Schedule for Clinical Assessment in Neuropsychiatry).  PE were coded as 
pƌeseŶt if oŶe oƌ ŵoƌe of the eǆpeƌieŶĐes ǁas ƌated as ͚suspeĐted oƌ defiŶitelǇ pƌeseŶt͛ ďǇ a tƌaiŶed 
psychologist.  UŶĐleaƌ ƌespoŶses afteƌ pƌoďiŶg ǁeƌe alǁaǇs ͚ƌated doǁŶ͛, aŶd symptoms only rated 
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as definite when a credible example was provided.  In our analysis we included only symptoms that 
could not be directly attributed to falling asleep/waking or to fever and were reported either in the 
PLIKSi at age 12 or in the PLIKSi at age 18 [35 36]. 
 
2.3 Exposures of interest: maternal smoking during pregnancy, paternal smoking during 
pregnancy and exposure to ETS in early childhood. 
Exposure to smoking in utero throughout pregnancy was based on maternal responses to specific 
questions asking about number of cigarettes smoked.  This was assessed at three time points: 8 
weeks gestation, 18 weeks gestation, and 8 weeks post-partum.  Paternal smoking during pregnancy 
was assessed at 8 weeks gestation.  Exposure to ETS in early childhood was defined as active 
maternal and/or paternal smoking at 1 year 9 months since birth, 2 years 9 months and 3 years 11 
months since birth. 
 
2.4 Confounding variables 
We identified a priori several potential maternal/paternal, socioeconomic and offspring confounding 
variables based on previous literature in this area: ŵotheƌ͛s age at delivery, maternal education 
level, maternal social class, marital status, low income, maternal history of depression, exposure to 
influenza, use of cannabis, alcohol and illicit drugs during pregnancy, offspring sex, birth weight and 
gestation at delivery [10, 11].  
 
2.5 Statistical analyses  
Median and interquartile ranges were used to summarise continuous variables, and count and 
percentages for categorical variables.  P-values were obtained using the Kruskal-Wallis and Chi-
squared test, and chi square for trend was used for ordinal variables (social class).  Univariate and 
multivariable logistic regression analyses were used to calculate odds ratios (OR) and 95% 
confidence intervals (95% CI) for hypomania as the dependent variable and with maternal smoking 
during pregnancy, paternal smoking during pregnancy and exposure to ETS in early childhood as the 
indpendent variables.  Multivariable logistic regressions were adjusted foƌ ŵotheƌ͛s age at delivery, 
maternal education level, maternal social class, marital status, low income, maternal history of 
depression,  exposure to influenza, use of cannabis, alcohol and hard drugs during pregnancy; 
offspring sex, birth weight and gestation at delivery.  
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In a secondary analysis, multinomial logistic regression was used to calculate the OR and 95% CI for 
exposure to maternal smoking in utero, paternal smoking in utero and childhood exposure to ETS 
using hypomania with and without previous lifetime experience PE as the dependent variable. This 
regression analysis also adjusted for the confounders listed above. Missing data was imputed using 
imputation by chained equatioŶs usiŶg the ͞iĐe͟ ŵodule in Stata. Twenty five data sets were created 
and then analysed. 
 
3. Results 
3.1 Baseline characteristics 
Overall, 220 (7·4%) of respondents satisfied criteria for hypomania and the remaining participants 
ǁeƌe Đlassified as a ͚Ŷo hǇpoŵaŶia͛ ĐoŵpaƌisoŶ gƌoup ;taďle ϭͿ.  The ŵediaŶ HCL-32 score was 19 
(IQR 16-23) in the hypomania group and 15 (IQR 11-19) iŶ the ͚Ŷo hǇpoŵaŶia͛ gƌoup ;p<Ϭ·001).  
Table 1 shows that the two groups did not differ in terms of most of the potential confounding 
variables, although the hypomania group were more likely to be male (41·8% versus 34·8%, 
p=0·035), and to have a mother who was aged under 30 (70·3% versus 59·0%, p=0·001). 
3.2 Smoking during pregnancy, paternal smoking, exposure to ETS and risk of hypomania 
There was weak evidence of an association between exposure to maternal smoking in utero and 
lifetime hypomania assessed in young adulthood: 21·2% of mothers in the hypomania group 
reported smoking throughout pregnancy, compared to 16·1% in the comparison group (P = 0·06; 
table 1).  Exposure to paternal smoking in pregnancy and ETS in early childhood had no effect on 
lifetime hypomania (P = 0·340 and P = 0·264 respectively; table 1).  Univariate logistic regression of 
lifetime hypomania with the three smoking exposure variables found no evidence of an association 
(table 3). This also remained the case after adjusting for confounding factors but there was some 
attenuation in the effect of maternal smoking, with odds ratio falling from 1·35 to 1·29 after 
adjustment (table 3). 
3.3 Smoking during pregnancy, paternal smoking and exposure to ETS and risk of ͚hypoŵaŶia 
with PE͛ 
In a secondary analysis, we tested for an association between in  utero maternal smoking, parental 
smoking in pregnancy and ETS exposure in childhood and lifetime hypomania with and without  
previous experience of PE, relative to controls with no history of either hypomania or PE.  The three 
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groups were similar in terms of most confounding factors but there was strong evidence of a 
difference in the proportion of mothers who reported smoking during pregnancy (32·6% in the 
͚hǇpoŵaŶia plus PE͛ gƌoup, ϭ6·4% in the ͚hǇpoŵaŶia, Ŷo PE͛ gƌoup, aŶd 13·9% in the control group; 
P = 0·002) (table 2). 
There was no association between paternal smoking during pregnancy (P = 0·571) and between ETS 
exposure in early childhood with risk of hypomania with PE (P = 0·446). The effect of maternal age 
differed across the three  groups (P = 0·004), as did exposure to gestational  influenza (P = 0·025) 
(table 3). 
We tested the above association further using multinomial logistic regression, with the control group 
as the base group (table 4) and ͚hypomania no PE͛ and ͚hǇpoŵaŶia plus PE͛ as the groups of primary 
interest.  Theƌe ǁas Ŷo assoĐiatioŶ ďetǁeeŶ the ͚hǇpoŵaŶia Ŷo PE͛ gƌoup ǁith aŶǇ of the thƌee 
smoking exposure variables.  However, foƌ the ͚hǇpoŵaŶia plus PE͛ gƌoup, the effect of maternal 
smoking in utero was significant in both univariate and multivariable analyses (multivariate OR = 
3·45, 95%CI 1·49 7·98, P = 0·004).   
 
4. Discussion 
Although we did not  find strong evidence of an association between maternal smoking during 
pregnancy and hypomania iŶ offspƌiŶg, theƌe ǁas aŶ assoĐiatioŶ ǁith ͚hǇpoŵaŶia plus pƌeǀious PE͛, 
suggesting that maternal smoking during pregnancy may be a risk factor for more severe forms of 
psychopathology occurring along the mood-psychosis spectrum.  We did not find any association 
between paternal smoking or exposure to ETS during childhood and any of the hypomania 
outcomes. 
It should be noted that our outcomes of interest (hypomania as defined by the HCL-32 and 
͚hypomania plus previous PEs͛) are not formal ICD-10 or DSM5 diagnoses but rather they are 
psychopathological constructs which permit an assessment of the impact of exposures on psychiatric 
phenotypes which cross the mood-psychosis spectrum.  This is clearly a limitation if the primary 
interest is strictly-defined bipolar disorder (as in ICD-10 or DSM5), but this approach has merit 
because it is consistent with with recent proposals, such as those within the Research Domain 
Criteria (RDoC), to move beyond restrictive categories of arbitrarily-defined disorder towards an 
assessment of psychiatric outcomes which cross traditional diagnostic boundaries; in this case, the 
mood-psychosis spectrum [43,44]. 
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Previous findings with regard to strictly-defined BD in this area are inconsistent.  Talati and 
colleagues identified a two-fold increase in risk for BD among offspring exposed to maternal smoking 
in utero [17] whereas Chudal and colleagues found no association [20].  Although both studies used 
a formal diagnosis of BD (rather than hypomania) as the primary outcome, neither took account of 
as wide a range of potential confounders as we have been able to do in our study, notably exposure 
to influenza during pregnancy and exposure to alcohol and drug use during pregnancy.  Further, the 
BD outcomes in the two previous studies were not sub-divided into BD with and without lifetime 
experience of psychotic features. 
Gestational influenza, one of the confounders considered in our study, may be a risk factor for more 
severe forms of BD [37,38,39].  The association with BD type II or hypomania has not been 
extensively investigated, although in our recent analysis of the ALSPAC cohort we found a weak 
association between gestational influenza and hypomania which did not survive adjustment for 
confounding factors [40].   
Our findings suggest that exposure to maternal smoking in utero may be a risk factor for more 
severe forms of BD characterised by both manic and psychotic features (such as BD type I), rather 
than non-psychotic forms of BD (such as BD type II).  This is consistent with previous work which has 
identified maternal smoking during pregnancy as a risk factor for psychosis-like symptoms [10] and 
schizophrenia [11] in offspring.  Very recently, Niemelä and colleagues reported that maternal 
smoking during pregnancy (indexed by cotinine level) was associated with an increased odds of 
schizophrenia in offspring (OR = 3·41, 95% CI 1·86–6·24) and that this association was not explained  
by maternal age, parental psychiatric disorder or socioeconomic status [41].   
 
4.1 Strengths and limitations 
The ALSPAC birth cohort is a large, well-characterised and representative sample from the UK and, 
relative to previous work, our study has the advantage of a prospective design and a relatively large 
sample size [21,22]. Our study also fills an important gap in the literature between clinical and 
population samples by assessing features of hypomania within a non-clinical cohort of young adults.  
This could be considered to represent an advance on previous reports because the level of detail 
available within the ALSPAC cohort permits a wider range of confounding factors to be taken into 
account. 
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However, we acknowledge some limitations.  Participant attrition has been an issue in studies using 
more recent outcome measures within ALSPAC and potentially a source of bias.  It is, however, 
possible that the effect sizes we have observed might be underestimates because offspring with 
bipolar features were more likely to not return their questionnaires.  Our outcome measure, the 
HCL-32, may be subject to reporting bias because it relies on self-report in areas such as risk-taking, 
sexual activity and alcohol use.  However, this instrument is well validated as a screening tool for 
bipolar disorder type II. [26,27]  It is also possible that respondents completed the HCL-32 with 
reference to a period of intoxication with recreational drugs, even though the opening statement 
speĐifiĐallǇ asks that theǇ ĐoŶsideƌ ͞a period when [they] were in a high state, not related to 
recreational drug use”.  There have not yet been sensitivity and specificity tests of the HCL-32 as a 
categorical measure which includes both duration and impact on functioning as criteria but it is likely 
that by including these features we improve sensitivity for a diagnosis of hypomania (previous 
methods have tended to focus solely on a threshold score on the HCL-32, usually 14 out of 32). 
[24,25,42]  
Other potential limitations relate to the self-reported nature of smoking by mothers: it is clearly 
possible that some mothers may have smoked during pregnancy but did not report this when asked.  
Further, there was a lack of information available on psychiatric comorbidity and substance abuse, 
although with a sample aged 22 this may not be important given that they will have not yet been 
assessed from a diagnostic perspective 
 
5.0 Conclusions 
Overall, within a birth cohort followed up into early adulthood, we found that maternal smoking 
during pregnancy (but not paternal smoking or exposure to ETS in childhood) was associated with 
increased risk of hypomania only in the context of a concomitant history of PE.  Maternal smoking 
during pregnancy, paternal smoking and exposure to ETS in childhood were all not associated with 
increased risk of hypomania without previous PE.  This suggests that maternal smoking during 
pregnancy may be a risk factor for more severe forms of psychopathology rather than simply 
hypomania.  Future work should explore associations between exposure to smoking in utero and 
dimensional aspects of psychopathology across affective and psychotic disorders, rather than with 
catergorical diagnoses defined solely by formal diagnostic systems such as ICD-10 and DSM5 [43,44]. 
 
 
  
11 
 
 
 
 
Acknowledgements 
We are extremely grateful to all the families who took part in this study and the midwives for their 
help in recruiting them.  The whole ALSPAC team, which includes interviewers, computer and 
laboratory technicians, clerical workers, research scientists, volunteers, managers, receptionists and 
nurses.  The ALSPAC is funded by the UK Medical Research Council, the Wellcome Trust and the 
University of Bristol provide core support.  This specific analysis was funded by a Strategic Start-Up 
Grant from the University of Glasgow to DJS.  DJS is supported by a Lister Institute Prize Fellowship. 
Disclosures 
None.  The authors report no conflicts of interest.  
  
  
12 
 
 
Table 1.  Maternal, pregnancy and offspring characteristics by presence or absence of hypomania 
in young adulthood. 
  
Hypomania 
N=220 
 
No hypomania 
N=2,737 
 
 
P value 
Maternal characteristics    
 N,  % N, %  
Age at delivery    
Age<=30 147 (70.3) 1,537 (59.0) 0.001 
Age>30 62 (29.7) 1,069 (41.0)  
Missing                   11              131  
    
Highest educational level 
Degree or above 41 (19.8) 544 (21.4) 0.588 
Other qualification 166 (80.2) 1,997 (78.6)  
Missing  196 13  
    
Social class    
    I 21 (11.4) 191 (8.5) 0.473 
    II 60 (32.4) 825 (36.6)  
    III 78 (42.2) 939 (41.7)  
    IV 14 (7.6) 131 (5.8)  
    V 9 (4.9) 144 (6.4)  
    VI 3 (1.6) 23 (1.0)  
Missing  35 484  
 
Maternal depression  
   
Yes 16 (7.9) 156 (6.1) 0.313 
No 186 (92.1) 2,387 (93.9)  
Missing  18 194  
 
Housing tenure 
   
Council tenant                                10 (4.9) 132 (5.2) 0.830 
Other tenure                                   196 (95.1) 2,407 (94.8)  
Missing  14 198  
 
Marital status 
   
Single                                             37 (18.1) 380 (14.8) 0.212 
Married                                            168 (81.9) 2,186 (85.2)  
Missing  15 171  
 
Income Support 
   
No income support                         189 (94.0) 2,397 (95.7) 0.259 
Income support                                            12 (6.0) 17 (4.3)  
Missing     
Pregnancy characteristics    
 Median (IQR) Median (IQR)  
Gestation at delivery 40 (39-41) 40 (39-41) 0.770 
Missing  
 
11 131  
 N (%) N (%)  
 
Gestational influenza 
   
Yes 46 (24.9) 469 (20.1) 0.121 
No 139 (75.1) 1,865 (79.9)  
Missing  35 403  
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Illicit drug use during 
pregnancy 
   
Yes                                              1 (0.5) 10 (0.39) 0.838 
No                                          205 (99.5) 2,542 (99.6)  
Missing  14 185  
 
Cannabis use during 
pregnancy 
   
Yes                                               7 (3.5) 81 (3.3) 0.868 
No                                             194 (96.5) 2,399 (96.7)  
Missing     
 
Alcohol use during 
pregnancy 
   
Yes                                              146 (70.9) 1,800 (70.4) 0.878 
No                                       60 (29.1) 758 (29.6)  
Missing  14 179  
Offspring characteristics    
 Median (IQR) Median (IQR)  
Age (years) 21.9 (21.5-22.4) 22.01 (21.5-22.4) 0.617 
Missing 2 
 
 
24  
 N (%) N (%)  
Sex    
Female 128 (58.2) 1786 (65.3) 0.035 
Male 92 (41.8) 951 (34.8)  
Missing N=0    
 
Child Ethnicity 
   
White                                             193 (96.5) 2,423 (96.3) 0.866 
Non-white                                        7 (3.5) 94 (3.7)  
Missing  20 220  
 Median (IQR) Median (IQR)  
Birth weight (g) 3,380 (3,100-3,720) 3,460 (3,120-3,760) 0.120 
Missing 14 162  
 Median (IQR) Median (IQR)  
HCL_32 score 19 (16-23) 15 (11-19) 0.001 
Missing N=0 
 
   
Smoking Exposure    
Maternal smoking during 
pregnancy T1,T2,T3 
   
Yes 44 (21.2) 419 (16.1)  
No 164 (78.9) 2,181 (83.9) 0.060 
Missing 12 137  
    
Paternal smoking during 
pregnancy 
   
Yes 30 (22.7) 317 (19.3)  
No 102 (77.3) 1,325 (80.7) 0.340 
Missing 220 1,095  
    
ETS exposure in early 
childhood 
   
Yes 68 (46.9) 875 (48.3)  
No 77 (53.1) 937 (51.7) 0.264 
Missing 75 925  
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Table 2.  Maternal, pregnancy and offspring characteristics: hypomania with and without PE, 
versus controls. 
  
Hypomania plus PE 
N=45 
 
 
Hypomania, no PE 
N=150 
 
Controls 
(N=2,088) 
 
 
P value 
 
Maternal 
characteristics 
    
 N (%) N (%) N (%)  
Age at delivery     
Age<=30 31 (72.1) 100 (70.9) 1,162 (58.7) 0.004 
Age>30 12 (27.9) 41 (29.1) 819 (41.3)  
Missing 2 9 107  
 
Highest educational 
level 
    
 N (%) N (%) N (%)  
Degree or above 9 (20.9) 28 (20.1) 434 (22.4) 0.813 
Other qualification 34 (79.1) 111 (79.9) 1,506 (77.6)  
Missing  2 11 148  
 
Social class 
    
    I 3 (7.3) 15 (12.2) 152 (8.75)  
    II 14 (34.2) 42 (34.2) 651 (37.5)  
    III 16 (39.0) 50 (40.7) 722 (41.5)  
    IV 4 (9.8) 9 (7.3) 97 (5.6)  
    V 3 (7.3) 6 (4.9) 105 (6.0)  
    VI 1 (2.4) 1 (0.8) 11 (0.6) 0.794 
 Missing  4 27 350  
     
 
Maternal depression  
    
Yes 4 (9.8) 9 (6.5) 107 (5.5) 0.458 
No 37 (90.2) 129 (93.5) 1,835 (94.5)  
Missing  4 12 146  
     
Housing tenure                  
Council house 3 (7.0) 6 (4.3) 75 (3.9)  
Other tenure 40 (93.0) 133 (95.7) 1,863 (96.1) 0.572 
Missing 2 11 150  
 
Marital status 
    
Single 9 (20.9) 22 (15.8) 278 (14.2) 0.409 
Married 34 (79.0) 117 (84.2) 1,682 (85.8)  
Missing  2 11 128  
 
Income support 
    
No 1,838 (96.1) 131 (95.6) 39 (90.7) 0.206 
Yes 75 (3.9) 6 (4.4) 4 (9.3)  
Missing  2 13 175  
Pregnancy 
characteristics 
    
 Median (IQR) Median (IQR) Median (IQR) 0.514 
Gestation at delivery 40 (39-41) 40 (39-41) 40 (39-41)  
Missing 2 9 107  
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Gestational influenza     
    Yes 14 (34.2) 30 (24.0) 342 (19.0) 0.025 
    No 27 (65.9) 95 (76.0) 1,454 (81.0)  
Missing 4 25 292  
  
N (%) 
 
N (%) 
 
N (%) 
 
Illicit drug use during 
pregnancy 
    
Yes              0 (0.0) 0 4 (0.21)  
No 42 (100.0) 139 (100.0) 1,943 (99.8) 0.830 
Missing            3 11 141  
Cannabis use during 
pregnancy 
    
Yes 1 (2.4) 5 (3.7) 63 (3.3)  
No 40 (97.6) 130 (96.3) 1,835 (96.7) 0.923 
Missing 4 15 190  
Alcohol use during 
pregnancy 
    
Female 32 (76.2) 101 (72.7) 1,402 (72.0)  
Male 10 (23.8) 38 (27.3) 546 (28.0) 0.824 
Missing  3 11 140  
Offspring 
Characteristics 
    
Age (years) 21.9 (21.5-22.4) 22.01 (21.5-22.4) 21.9 (21.5-22.4) 0.963 
Missing  2 0 14  
 Median (IQR) Median (IQR) Median (IQR) 0.181 
Birth weight 3,390 (3,180-3,620) 3,370 (3,080-3,700) 3,460 (3,140-3,740)  
Missing  3 11 129  
 N(%) N(%) N(%)  
Sex     
Female 29 (64.4) 84 (56.0) 1,328 (63.6)  
Male 16 (35.6) 66 (44.0) 760 (36.4) 0.173 
Missing = 0     
  
Median (IQR) 
 
Median (IQR) 
 
Median (IQR) 
 
0.001 
HCL_32 score 20 (18-23) 19 (16-22) 15 (11-19)  
     
     
     
Smoking Exposure     
     
Maternal smoking 
during pregnancy 
(T1,T2,T3) 
    
Yes 14 (32.6) 23 (16.4) 274 (13.9)  
No 29 (67.4) 117 83.6) 1,704 (86.2) 0.002 
Missing 2 10 110  
     
Paternal smoking 
during pregnancy 
    
Yes 7 (23.3) 19 (21.1) 230 (17.9)  
No 23 (76.7) 71 (78.9) 1,055 (82.1) 0.571 
Missing 15 60 803  
     
ETS exposure in early 
childhood 
    
Yes 17 (50.0) 50 (51.0) 623 (45.0)  
  
17 
 
 
No 17 (50.0) 48 (49.0) 761 (55.0) 0.446 
Missing 11 52 704  
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Table 3  Exposure to maternal smoking, paternal smoking or ETS during childhood and hypomania 
binary dependent variable (multiple imputation results). 
 Hypomania  
Univariable   
 OR   95% CI P value 
Maternal smoking 1.35 (0.88, 2.09) 0.170 
Paternal smoking 1.19 (0.62, 2.29) 0.591 
Exposure to ETS during childhood 0.92 (0.50, 1.70) 0.793 
   
   
Multivariable   
   
Maternal smoking 1.29 (0.83, 2.00) 0.259 
Paternal smoking 1.24 (0.64, 2.43) 0.435 
Exposure to ETS during childhood 0.91 (0.48, 1.72) 0.762 
Multivariable model is adjusted for high maternal age, maternal education (degree), maternal social 
class, maternal depression, offspring sex, marital status, income support recipient, gestational 
influenza, estimated gestational age, cannabis use during pregnancy, alcohol use during pregnancy 
and low birthweight. OR = odds ratio 
 
Table 4  Exposure to maternal smoking, paternal smoking or ETS during childhood and hypomania 
with and without previous PE (multiple imputation results) 
 Hypomania without PE Hypomania with PE 
Univariable     
 OR   95% CI P value OR   95% CI P value 
Maternal smoking 1.06 (0.64, 1.76) 0.810 3.31 (1.50, 7.27) 0.003 
Paternal smoking 1.31 (0.62, 2.79) 0.480 0.82 (0.28, 2.39) 0.721 
Exposure to ETS during childhood 0.94 (0.46, 1.91) 0.862 0.78 (0.26, 2.31) 0.657 
     
     
Multivariable     
     
Maternal smoking 1.00 (0.59, 1.68) 0.989 3.45 (1.49, 7.98) 0.004 
Paternal smoking 1.41 (0.64, 3.09) 0.383 0.83 (0.26, 2.65) 0.758 
Exposure to ETS during childhood 0.95 (0.45, 1.99) 0.884 0.68 (0.22, 2.13) 0.511 
PE = psychotic experiences.  Multivariable model is adjusted for high maternal age, maternal 
education (degree), maternal social class, maternal depression, offspring sex, marital status, income 
support recipient, gestational influenza, estimated gestational age, cannabis use during pregnancy, 
alcohol use during pregnancy and low birthweight.  OR = odds ratio 
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